Zyla Life Sciences Net Cash Provided by (Used in) Continuing Operations
Zyla Life Sciences reported Net Cash Provided by (Used in) Continuing Operations of $1.15 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2015-05-08
- Zyla Life Sciences net cash provided by (used in) continuing operations for the quarter ending 2015-03-31 was $1.15M, a 98.14% decline year-over-year.
- Zyla Life Sciences net cash provided by (used in) continuing operations for the quarter ending 2014-12-31 was -$6.99M, a 233.42% decline year-over-year.
- Zyla Life Sciences net cash provided by (used in) continuing operations for the quarter ending 2014-09-30 was -$9.53M, a 229.63% decline year-over-year.
- Zyla Life Sciences net cash provided by (used in) continuing operations for the quarter ending 2014-06-30 was -$8.19M, a 432.16% decline year-over-year.
- Zyla Life Sciences net cash provided by (used in) continuing operations for fiscal 2014 was $37.04M, a 201.22% increase from fiscal 2013.
- Zyla Life Sciences net cash provided by (used in) continuing operations for fiscal 2013 was $12.30M, a 422.79% increase from fiscal 2012.
- Zyla Life Sciences net cash provided by (used in) continuing operations for fiscal 2012 was $2.35M.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2015-03-31 | $1.15M 10-Q · filed 2015-05-08 | -$5.84M derived: sum of 2 quarters · filed 2015-05-08 | -$15.37M derived: sum of 3 quarters · filed 2015-05-08 | -$23.56M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-12-31 | -$6.99M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | -$16.52M derived: sum of 2 quarters · filed 2015-03-16 | -$24.71M derived: sum of 3 quarters · filed 2015-03-16 | $37.04M 10-K · filed 2015-03-16 |
| 2014-09-30 | -$9.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$17.73M derived: sum of 2 quarters · filed 2014-11-14 | $44.02M 10-Q · filed 2014-11-14 | $49.26M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-06-30 | -$8.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $53.56M 10-Q · filed 2014-08-14 | $58.80M derived: sum of 3 quarters · filed 2015-05-08 | $66.15M derived: sum of 4 quarters · filed 2015-05-08 |
| 2014-03-31 | $61.75M 10-Q · filed 2015-05-08 | $66.99M derived: sum of 2 quarters · filed 2015-05-08 | $74.34M derived: sum of 3 quarters · filed 2015-05-08 | $76.81M derived: sum of 4 quarters · filed 2015-05-08 |
| 2013-12-31 | $5.24M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $12.59M derived: sum of 2 quarters · filed 2015-03-16 | $15.06M derived: sum of 3 quarters · filed 2015-03-16 | $12.30M 10-K · filed 2015-03-16 |
| 2013-09-30 | $7.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $9.82M derived: sum of 2 quarters · filed 2014-11-14 | $7.06M 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $2.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$296.00K 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | -$2.76M 10-Q · filed 2014-06-11 | |||
| 2012-12-31 | $2.35M 10-K · filed 2015-03-16 |